RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human trial tests 'Supercharged' donor cells against tough head & neck cancers
Disease control CompletedThis early-stage study tested the safety of a new combination treatment for advanced head and neck cancer. It involved giving patients immune cells from a donor, along with several drugs, to see if the body could better fight the cancer. The main goal was to find a safe dose and …
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New combo attack on tough head and neck cancers
Disease control CompletedThis study tested a two-part treatment for advanced head and neck cancer that had returned or spread. It combined a short, intense course of radiation with an immunotherapy drug called pembrolizumab. The goal was to see if this combination could shrink tumors and control the canc…
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC